Trogenix

Trogenix, founded in 2023, is a leading biotechnology company dedicated to developing innovative cancer therapies. Trogenix integrates cutting-edge technologies from the fields of genomics, oncology, immunotherapy, and gene therapy to create a revolutionary treatment method through its Odysseus® platform. Using proven AAV vectors, proprietary synthetic super enhancers (SSE) are directly delivered to tumor cells without detection. SSE enables unprecedented precision in gene control, effectively revealing cancer to the human immune system and killing tumor cells.